Asensus Surgical — Cellular Technical Services — UBS Global Life Sciences Conference 2007
24 slides from Asensus Surgical's conference presentation, Sep 27, 2007
Slide 1: Endoscopic and Minimally Invasive Surgical Devices
Stewart Davis MD, COO Endoscopic and Minimally Invasive Surgical Devices September 2007
Slide 2: Forward-looking statements
This presentation contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA),regarding product development efforts and other non- historical facts about our expectations, beliefs or intentions regarding our business, technologies
Slide 3: Founders and key backers
Phillip Frost M.D. Former Chairman and CEO of IVAX; Chairman, CEO and President of Opko Health; The Frost Group Jane Hsiao Ph.D. Former Vice-Chairman of IVAX; Vice Chairman and CTO of Opko Health; The Frost Group Jeffrey G. Spragens Charles J. Filipi M.D. Multiple commercially successful medical dev
Slide 4: Obesity, GERD and Barrett's Esophagus
Obesity Almost 30% of the US population GastroEsophageal Reflux Disorder (GERD) Barrett's Esophagus Barrett's Esophagus Barrett's Esophagus Barrett's Esophagus Barrett's Esophagus
Slide 5: Management team
Jeffrey G. Spragens - Chief Executive Officer and President Founder and Business Manager of SafeStitch LLC; Former Founder and Director of North American Vaccine Corporation; Co-Founder and Director of Foundation for Peace; Co-Founder of Mint Management and Development Stewart B. Davis M.D. - Chief
Slide 6: Board of directors
Jane Hsiao Ph.D. - Chairman of the Board Jeffrey G. Spragens Charles J. Filipi M.D. Steven Rubin Executive Vice President of Opko Health, The Frost Group, Former Senior Vice President, General Counsel and Secretary of IVAX Richard Pfenniger, Jr. CEO and President of Continucare Corporation Kevin Way
Slide 7: Medical advisors
Richard Rothstein M.D. Dartmouth University; World Renowned Gastroenterologist and Expert in GERD, Barrett's Esophagus and NOTES Raul Rosenthal M.D. Cleveland Clinic; World Renowned Bariatric Surgeon Lee Swanstrom M.D. Oregon Clinic; World Renowned Laparoscopic and Endoscopic Surgeon; First Surgeon
Slide 8: SafeStitch share exchange with Cellular Technical Services
September 4, 2007 - SafeStitch LLC closed share exchange with Cellular Technical Services Company (OTCBB: CTSC) Well funded and access to additional funds Strong pipeline of products Some products to launch in 2008, others in clinical trials in 2008 Strong relationship with Creighton University Stro
Slide 9: Obesity prevalence map
No Data 15%-19% 20%-24% ^25% (*BMI ^30, or ~ 30 lbs overweight for 5' 4" person) (*BMI ^30, or ~ 30 lbs overweight for 5' 4" person)
Slide 10: Obesity and bariatric procedures
Linked to heart disease, diabetes and many more diseases Procedures for obese patients have become household names All involve abdominally surgery High risk patients, with high morbidity and mortality for these procedures Currently, 350,000 - 400,000 bariatric procedures are performed Worldwide, eac
Slide 11: Advantages of the obesity procedure
Advantages: Outpatient procedure Safer Faster recovery Durability of effect Significant cost reduction Clinical Trials to begin in 2008 (First Quarter)
Slide 12: GastroEsophageal Reflux Disorder
GastroEsophageal Reflux Disorder Heartburn, indigestion Multibillion market in pharmaceuticals alone GERD can lead to Barrett's Esophagus, which may lead to cancer 200,00 to 250,000 GERD procedures are currently performed Worldwide, each year currently performed Worldwide, each year currently perfor
Slide 13: Same device for GERD: advantages
Same device Advantages: Outpatient procedure Safer Easier and Quicker Durability of effect Significant cost reduction Clinical Trials to begin in 2008 (First Quarter)
Slide 14: Intraluminal Gastroplasty Device
Intraluminal Gastroplasty Device
Slide 15: Barrett's Esophagus
For treatment and diagnosis of Barrett's Esophagus Condition in which the esophagus changes so that some of its lining is replaced by a type of tissue similar to that normally found in the intestine, intestinal metaplasia GERD is most common cause May lead to esophageal cancer Conservatively, ~11 mi
Slide 16: Barrett's excision and ablation device advantages
Advantages: Large piece of tissue excised; can be sent for histology Clean margins Easier and Quicker Cost reduction Clinical Trials to begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008 begin in 2008
Slide 17: Product pipeline
Intraluminal Gastroplasty Device For Obesity For GERD Barrett's Excision and Ablation Device SMART Dilator Standard Bite Block Airway Bite Block T Fastener Novel Surgical Fasteners Novel Devices for Natural Orifice Transluminal Endoscopic Surgery (NOTES) Endoscopic Surgery (NOTES) Endoscopic Surgery
Slide 18: SMART Dilator
800,000 dilations of esophageal strictures are performed annually in the U.S.; ~2 million Worldwide Disposable: other disposable dilators sell for $150 - $250 Perforation Rate: ~1.1% Important Features Visual feedback force gauge handle Tapered tip Endoscope channel through entire device 510(k) FDA
Slide 19: SMART Dilator
SMART Dilator ae > 4 yA é
Slide 20: Standard Bite Block
Approximately 18 - 20M upper endoscopies done per year Worldwide and all procedures need bite blocks to prevent injury to endoscopes and the patients' teeth Class I, 510(k) exempt device Advantages: Harder to expel from mouth Softer material Superior crush resistance Larger working inner diameter Cl
Slide 21: Airway Bite Block
Approximately 5M upper endoscopies done per year Worldwide, on obese patients The majority of these patients have airway problems during procedure, which require some intervention Class I, 510(k) exempt device Advantages: Novel design integrating Standard Bite Block and Oral-Pharyngeal airway Softer
Slide 22: T Fastener and novel NOTES devices
T Fastener For Upper GI Bleeding and closing gastrotomies following NOTES T Fastener can be placed using multi-firing endoscopic device High mortality rate due to Upper GI bleeding Needs to be treated quickly and effectively Novel Surgical Fasteners Can be used for Hernia repair and other surgical p
Slide 23: Large, important and growing markets
Large, important and growing markets Obesity, GERD and Barrett's Multibillion markets, currently Unique devices Outpatient and minimally invasive Reduce cost to society from obesity and obesity-related diseases obesity-related diseases obesity-related diseases obesity-related diseases obesity-relate
Slide 24: Contact: Stewart B. Davis M.D.
Endoscopic and Minimally Invasive Surgical Devices Contact: Stewart B. Davis M.D. Chief Operating Officer 4400 Biscayne Boulevard Suite 980 Miami, FL 33137 (305) 575-4145 (305) 575-4130 Fax sbdavis@safestitch.com sbdavis@safestitch.com sbdavis@safestitch.com sbdavis@safestitch.com sbdavis@safestitch
Cellular Technical Services — UBS Global Life Sciences Conference 2007 on 6ix